本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德康醫療

83.33
+1.942.38%
盤前:84.000.6700+0.80%08:08 EST
成交量:301.36萬
成交額:2.50億
市值:310.78億
市盈率:32.68
高:83.66
開:82.01
低:81.39
收:81.39
52周最高:92.59
52周最低:56.72
股本:3.73億
流通股本:3.72億
量比:0.82
換手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):2.55
每股收益(LYR):2.09
淨資產收益率:37.67%
總資產收益率:11.13%
市淨率:12.26
市盈率(LYR):39.88

資料載入中...

2026/11/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/10/29

重要事件披露

Form 8-K - Current report
2026/10/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/10

重要事件披露

Form 8-K - Current report
2026/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report